Thomas P. Schnettler, Director at Akoya Biosciences, Inc. (AKYA), sold 142,100 shares at $13.03 ($1.9M) on 2022-12-13, disclosed to the SEC on 2022-12-20.
Open-market sale of $1.9M AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 71,050 | $926K | 50.0% |
| 2 | $13.03 | 71,050 | $926K | 50.0% |
| Total | $13.03 avg | 142,100 | $1.9M | 100% |